{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:10:38Z","timestamp":1789603838286,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.prp.2023.154916","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T23:23:33Z","timestamp":1699053813000},"page":"154916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas"],"prefix":"10.1016","volume":"253","author":[{"given":"Xiaobo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154916_bib1","article-title":"Fumarase-deficient uterine leiomyomas an immunohistochemical, molecular genetic, and clinicopathologic study of 86 cases","author":"Butzow","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2023.154916_bib2","article-title":"Novel FH mutations in families with hereditary leiomyomatosis and renal cell center (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma (vol 48, pg 226, 2011)","volume":"48","author":"Gardie","year":"2011","journal-title":"J. Med. Genet."},{"issue":"10","key":"10.1016\/j.prp.2023.154916_bib3","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2023.154916_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","article-title":"Fumarate hydratase\u2013deficient uterine leiomyomas occur in both the syndromic and sporadic settings","volume":"40","author":"Harrison","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154916_bib5","doi-asserted-by":"crossref","unstructured":"Y.Y. A, M.Z.. B, W.Z.. A, F.Z.. C, B.G.. A, Q.S.. A, F.Y.. A, Q.H.. A, X.L.. A, Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature, Urologic oncology 39(11) 791.e9\u2013791.e16.","DOI":"10.1016\/j.urolonc.2021.07.026"},{"key":"10.1016\/j.prp.2023.154916_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.humpath.2022.05.016","article-title":"Clinicopathological and molecular characteristics of fumarate hydratase-deficient uterine smooth muscle tumors: a single-center study of 52 cases","volume":"126","author":"Hui Li","year":"2022","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154916_bib7","first-page":"46","article-title":"Comparison of 2SC, AKR1B10, and FH antibodies as potential biomarkers for FH-deficient uterine leiomyomas","volume":"4","author":"Ahvenainen","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154916_bib8","unstructured":"T.W.C.o.T.E. Board., Who classification of tumours of female reproductive organs., (2020) 451\u2013459."},{"issue":"1","key":"10.1016\/j.prp.2023.154916_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-Part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur. Urol."},{"issue":"12","key":"10.1016\/j.prp.2023.154916_bib10","article-title":"PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood, clinical cancer research an official","volume":"23","author":"Schultz","year":"2017","journal-title":"J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.prp.2023.154916_bib11","doi-asserted-by":"crossref","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","author":"Toro","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.prp.2023.154916_bib12","article-title":"Hereditary leiomyomatosis and renal cell cancer","volume":"1","author":"Hansen","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.prp.2023.154916_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejogrb.2014.05.029","article-title":"Long-term risk of fibroid recurrence after laparoscopic myomectomy","volume":"180","author":"Radosa","year":"2014","journal-title":"Eur. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.prp.2023.154916_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jmig.2007.06.003","article-title":"Predictors of leiomyoma recurrence after laparoscopic myomectomy","volume":"14","author":"Yoo","year":"2007","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"7","key":"10.1016\/j.prp.2023.154916_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254142","article-title":"A prognostic index model for predicting long-term recurrence of uterine leiomyoma after myomectomy","volume":"16","author":"Ming","year":"2021","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.prp.2023.154916_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/gcc.22905","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening","volume":"60","author":"Garg","year":"2021","journal-title":"Genes, Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.prp.2023.154916_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/his.14007","article-title":"Prevalence of somatic and germline mutations of fumarate hydratase in uterine leiomyomas from young patients","volume":"76","author":"Liu","year":"2019","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.prp.2023.154916_bib18","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.3390\/cancers12113277","article-title":"Hereditary leiomyomatosis and renal cell cancer syndrome in spain: clinical and genetic characterization","volume":"12","author":"S\u00e1nchez-Heras","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2023.154916_bib19","doi-asserted-by":"crossref","unstructured":"Charushree, Prasad, P. Melanie, Napier, A. Charles, Rupar, Chitra, Fumarase deficiency: a rare disorder on the crossroads of clinical and metabolic genetics, neurology and cancer, Clinical dysmorphology (2017).","DOI":"10.1097\/MCD.0000000000000148"},{"key":"10.1016\/j.prp.2023.154916_bib20","unstructured":"B. Popp, R. Erber, C. Kraus, G. Vasileiou, J. Hoyer, S. Burghaus, A. Hartmann, M.W. Beckmann, A. Reis, A. Agaimy, Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants, Modern Pathology."},{"issue":"7","key":"10.1016\/j.prp.2023.154916_bib21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/modpathol.2013.215","article-title":"Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry","volume":"27","author":"Reyes","year":"2014","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2023.154916_bib22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/PAS.0000000000001293","article-title":"Detailed morphologic and immunohistochemical characterization of myomectomy and hysterectomy specimens from women with hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC)","volume":"43","author":"Chan","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154916_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2023.154916_bib24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/gcc.22643","article-title":"Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations","volume":"57","author":"Xie","year":"2018","journal-title":"Genes, Chromosomes Cancer"},{"key":"10.1016\/j.prp.2023.154916_bib25","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"6","author":"Launonen","year":"2001","journal-title":"Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.prp.2023.154916_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.prp.2023.154916_bib27","unstructured":"Bialik, Weigelt, Britta, Oliva, Esther, Schultheis, M. Anne, Young, H.. Robert, Chiang, Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T06:50:02Z","timestamp":1730875802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823006179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":27,"alternative-id":["S0344033823006179"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154916","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of Clinicopathological, immunohistochemistry and molecular detection in the diagnosis of fumarate hydratase-deficient uterine leiomyomas","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154916"}}